BioRestorative Therapies, Inc. ( BRTX) - Key Metrics
BRTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | $0.03 | -$2.43 | -$4.30 | -$4.30 |
| 2025Q4 | $0.04 | -$7.23 | -$5.44 | -$5.62 |
| 2025Q3 | $0.03 | -$6.67 | -$6.36 | -$6.36 |
| 2025Q2 | $0.69 | -$6.08 | -$6.16 | -$6.16 |
| 2025Q1 | $0.06 | -$12.78 | -$6.65 | -$6.74 |
BRTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | -0.28% | -0.57 |
| 2025Q4 | 0% | -0.82 |
| 2025Q3 | 0% | -1.10 |
| 2025Q2 | 0% | -1.39 |
| 2025Q1 | 0% | -0.70 |
BRTX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -78.97% | 0.13% |
| 2025Q4 | -23.82% | 0% |
| 2025Q3 | -21.95% | 0% |
| 2025Q2 | -18.46% | 0% |
| 2025Q1 | -18.92% | 0% |
BRTX
Price: $1.77
52 week price:
Payout Ratio Range:
Earnings Per Share: -21.40 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 19500
Market Capitalization: 2.6 million